Osteoporosis Therapy Pipeline Report (Related Reports)

Osteoporosis Therapy Pipeline Report


January 6, 2011
418 Pages - SKU: LSA6084484
Attention: There is an updated edition available for this report.
License type:
Online Download      US $1,495.00
Global Site License      US $3,737.50
Polycythemia Vera - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Polycythemia Vera - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H1 2014’, provides an overview of the Polycythemia Vera’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polycythemia  |  read more...
$2,000.00
Bacterial Pneumonia - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Bacterial Pneumonia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bacterial Pneumonia - Pipeline Review, H1 2014’, provides an overview of the Bacterial Pneumonia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bacterial  |  read more...
$2,000.00
Retinal Vein Occlusion - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Retinal Vein Occlusion - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Retinal Vein Occlusion - Pipeline Review, H1 2014’, provides an overview of the Retinal Vein Occlusion’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Bone Marrow Transplantation - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Bone Marrow Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bone Marrow Transplantation - Pipeline Review, H1 2014’, provides an overview of the Bone Marrow Transplantation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017
3/27/2014 | published by: GlobalData
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on  |  read more...
$5,995.00
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022
3/27/2014 | published by: GlobalData
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022 Summary Ankylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, and is one of the most common rheumatic conditions throughout the world.  |  read more...
$3,995.00
Food Allergy - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Food Allergy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Food Allergy - Pipeline Review, H1 2014’, provides an overview of the Food Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Food  |  read more...
$2,000.00
Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight
4/1/2014 | published by: FirstWord
Introduction Approval of Gilead’s once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV). With efficacy over 90% in GT1/2/3/4 patients, this safe, best in  |  read more...
$4,995.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Pertussis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Pertussis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2014’, provides an overview of the Pertussis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative  |  read more...
$2,000.00